Oncotarget (a primarily oncology-focused, peer-reviewed, open access journal) aims to maximize research impact through insightful peer-review; eliminate borders between specialties by linking different fields of oncology, cancer research and biomedical sciences; and foster application of basic and clinical science.
Its scope is unique. The term "oncotarget" encompasses all molecules, pathways, cellular functions, cell types, and even tissues that can be viewed as targets relevant to cancer as well as other diseases. The term was introduced in the inaugural Editorial,
Introducing Oncotarget.
As of January 1, 2022, Oncotarget has shifted to a continuous publishing model. Papers will now be published continuously within yearly volumes in their final and complete form and then quickly released to Pubmed.
Publication Alerts
Subscribe to receive alerts once a paper has been published by Oncotarget.
Mehran Karimzadeh, Pouria Jandaghi, Andreas I. Papadakis, Sebastian Trainor, Johan Rung, Mar Gonzà lez-Porta, Ghislaine Scelo, Naveen S. Vasudev, Alvis Brazma, Sidong Huang, Rosamonde E. Banks, Mark Lathrop, Hamed S. Najafabadi, Yasser Riazalhosseini
Published May 18, 2018 · Vol. 9, No. 38 · pp. 25166-25180
Marisa Sanchez, Zebin Xia, Elizabeth Rico-Bautista, Xihua Cao, Michael Cuddy, David J. Castro, Ricardo G. Correa, Liqun Chen, Jinghua Yu, Andrey Bobkov, Vivian Ruvolo, Michael Andreeff, Robert G. Oshima, Shu-Ichi Matsuzawa, John C. Reed, Xiao-Kun Zhang, Donna Hansel, Dieter A. Wolf, Marcia I. Dawson
Published May 18, 2018 · Vol. 9, No. 38 · pp. 25057-25074
Amy J.C. Dohmen, Joyce Sanders, Sander Canisius, Ekaterina S. Jordanova, Else A. Aalbersberg, Michiel W.M. van den Brekel, Jacques Neefjes, Charlotte L. Zuur
Published May 18, 2018 · Vol. 9, No. 38 · pp. 25034-25047